KLOW 80mg
$75.00
In stock (can be backordered)
SSL Secured
Secure Checkout
Guaranteed Delivery
Third-Party Tested
Buy KLOW 80mg—Quad-Peptide Research Blend
KLOW is a proprietary pre-combined research blend containing four mechanistically distinct peptide compounds in a single co-lyophilized vial: KPV (10mg alpha-MSH anti-inflammatory tripeptide), GHK-Cu (50mg copper tripeptide for cellular renewal research), BPC-157 (10mg gastric pentadecapeptide for tissue repair and angiogenesis), and TB-500 (10mg Thymosin Beta-4 fragment for systemic cell migration). Total peptide content: 80mg.
Each component addresses a different biological signaling dimension—anti-inflammatory pathway, cellular renewal and gene expression, local vascular repair, and systemic cell migration. Together they provide a multi-pathway research tool for studying the intersection of repair, renewal, and regeneration biology in laboratory models. The GHK-Cu dominant proportion (50mg of 80mg total) reflects its role as the longevity/cellular renewal compound that anchors this blend’s categorization in Cognitive & Longevity.
Four-Component Research Mechanism
KPV (10mg)—Anti-Inflammatory Pathway
Alpha-MSH C-terminal tripeptide. Studied for melanocortin receptor (MC1R/MC3R/MC4R) interaction and NF-kappaB pathway suppression. Provides the anti-inflammatory signaling dimension in the KLOW blend.
GHK-Cu (50mg)—Cellular Renewal & Gene Expression
Glycyl-histidyl-lysine copper complex. Studied for modulation of 4,000+ human genes including upregulation of DNA repair, antioxidant response, and tissue remodeling genes. The dominant component of KLOW—provides the cellular renewal research dimension.
BPC-157 (10mg)—Local Angiogenesis & Tissue Repair
Gastric pentadecapeptide. VEGFR2 signaling and eNOS activation. Provides the local vascular repair and angiogenesis initiation dimension in the KLOW blend.
TB-500 (10mg)—Systemic Cell Migration
Thymosin Beta-4 actin-binding fragment. G-actin sequestration and cell migration promotion. Provides the systemic cellular migration and structural remodeling dimension—complementary to BPC-157’s local angiogenic activity.
Product Specifications
| Compound | KLOW Blend (Proprietary Quad-Peptide) |
| Component 1 | KPV 10mg - Alpha-MSH tripeptide (anti-inflammatory) |
| Component 2 | GHK-Cu 50mg - Copper tripeptide (cellular renewal/gene expression) |
| Component 3 | BPC-157 10mg - Gastric pentadecapeptide (tissue repair/angiogenesis) |
| Component 4 | TB-500 10mg - Thymosin Beta-4 fragment (cell migration) |
| Total Content | 80mg co-lyophilized blend |
| Form | Lyophilized powder (co-lyophilized quad-blend) |
| Purity | >99% HPLC Verified for each component - Batch COA Available |
| Available Size | 80mg total (single vial) |
| Storage | Lyophilized: -20°C | Reconstituted: 2-8°C, use within 28 days |
| Reconstitution | Bacteriostatic Water (BAC Water) |
| Intended Use | Research Use Only (RUO) |
Frequently Ask Questions
